AJ91.F DocCheck AG
- Market cap
- EUR 52.3M
- P/E
- 11.2x
- P/B
- 1.36x
- ROE
- 12.8%
- Dividend yield
- 7.28%
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is AJ91.F undervalued?
Graham numberAJ91.F trades 17.6% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
DocCheck AG fundamental analysis
No fundamental analysis for DocCheck AG yet.
DocCheck AG stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About DocCheck AG
DocCheck AG provides community, agency, and e-commerce services for the healthcare sector in Europe. It focuses on agency, access, and retail businesses. The company develops and implements communication concepts for healthcare and business-to-business sectors using both new and traditional media; sells medical supplies and medical technology through mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertisin…
Full company profileDocCheck AG financial statements
DocCheck AG annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||
| Revenue | 25.9M | 28.1M | 28.3M | 32.4M | 63.1M | 85.9M | 60.9M | 53.4M | 53.8M | 55.3M |
| Gross Profit | 17.3M | 18.9M | 19.5M | 22.5M | 36.0M | 43.5M | 38.2M | 35.9M | 35.9M | 37.3M |
| Operating Income | 3.90M | 3.47M | 3.27M | 4.26M | 13.3M | 16.4M | 9.02M | 3.17M | 6.37M | 8.78M |
| EBITDA | - | 4.57M | 4.68M | 6.56M | 15.9M | 20.1M | 13.4M | 9.58M | 10.2M | 11.6M |
| Net Income | 2.66M | 2.41M | 2.27M | 3.14M | 9.20M | 11.4M | 6.29M | 2.27M | 5.28M | 5.33M |
| EPS | - | 0.48 | 0.46 | 0.63 | 1.83 | 2.27 | 1.25 | 0.45 | 1.04 | 1.05 |
| Balance Sheet | ||||||||||
| Total Assets | 25.8M | 27.0M | 27.9M | 31.6M | 45.0M | 56.7M | 60.1M | 56.1M | 58.1M | 55.7M |
| Total Liabilities | 5.61M | 6.34M | 7.00M | 9.58M | 13.7M | 18.6M | 20.7M | 18.1M | 18.0M | 14.1M |
| Shareholders' Equity | 20.0M | 20.5M | 20.8M | 22.0M | 30.9M | 37.3M | 38.6M | 37.3M | 40.1M | 41.6M |
| Cash & Short-term Investments | 8.60M | 7.98M | 9.41M | 7.99M | 17.5M | 18.2M | 13.4M | 14.4M | 17.0M | 14.5M |
| Cash Flow | ||||||||||
| Operating Cash Flow | 2.73M | 2.86M | 3.82M | 1.79M | 11.5M | 10.9M | 5.95M | 7.51M | 7.64M | 5.98M |
| Capital Expenditure | 662K | 828K | 2.12M | 908K | 3.29M | 3.88M | 6.37M | 1.89M | 1.13M | 3.74M |
| Free Cash Flow | - | 1.86M | 1.29M | 745K | 8.13M | 6.92M | -495K | 5.62M | 6.51M | 2.24M |
| Ratios | ||||||||||
| ROE | 13.3% | 11.8% | 10.9% | 14.3% | 29.8% | 30.6% | 16.3% | 6.1% | 13.2% | 12.8% |
| ROA | 10.3% | 8.9% | 8.2% | 9.9% | 20.4% | 20.1% | 10.5% | 4.0% | 9.1% | 9.6% |
| Net Profit Margin | 10.3% | 8.6% | 8.0% | 9.7% | 14.6% | 13.3% | 10.3% | 4.3% | 9.8% | 9.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
DocCheck AG dividends
- Dividend yield
- 7.28%
- Forward dividend
- 1.00 EUR
- Payout ratio
- 71.3%
- Ex-dividend date
- May 29, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | EUR 3.81M | 0.75 | 71.3% |
| 2024 | EUR 2.54M | 0.50 | 48.0% |
| 2023 | EUR 3.79M | 0.75 | 166.8% |
| 2022 | EUR 5.03M | 1.00 | 80.0% |
| 2021 | EUR 5.03M | 1.00 | 44.1% |
| 2020 | EUR 499K | 0.10 | 5.4% |
| 2019 | EUR 2.00M | 0.40 | 63.6% |
| 2018 | EUR 2.00M | 0.40 | 87.7% |
| 2017 | EUR 2.00M | 0.40 | 82.8% |
| 2016 | EUR 2.00M | - | 74.9% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns DocCheck AG
- Insiders 72.07%
- Institutions 7.90%
- Public & others 20.03%
- Shares outstanding 5.07M
- Free float 1.44M
DocCheck AG company profile
- Company name
- DocCheck AG
- Ticker
- AJ91.F
- ISIN
- DE000A1A6WE6
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Health Care Technology
- Employees
- 414
- Fiscal year end
- December
- Address
- Vogelsanger Str. 66, Cologne, Germany, 50823
- Phone
- 49 221 92053
- Website
- doccheck.ag
About DocCheck AG
DocCheck AG provides community, agency, and e-commerce services for the healthcare sector in Europe. It focuses on agency, access, and retail businesses. The company develops and implements communication concepts for healthcare and business-to-business sectors using both new and traditional media; sells medical supplies and medical technology through mail order to various medical professional groups, and invests in healthcare sectors, as well as involved in online advertising, market research, online studies, and paid content for healthcare market players. It also operates platform for information exchange, online services, and e-commerce in this market. DocCheck AG was founded in 1990 and is based in Cologne, Germany.
DocCheck AG management
4- Dr. Frank Nicolas AntwerpesPresident of the Management Board & CEO
- Mr. Philip Stadtmann M.B.A.CFO & Member of Management Board
- Mr. Thilo KolzerCOO & Member of Management Board
- Mr. Jens KnoopCTO & Member of Management Board